Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia

Owing to the more recent positive results with the anti-CD33 immunotoxin gemtuzumab ozogamicin, therapy against acute myeloid leukemias (AMLs) targeting CD33 holds many promises. Here, CD33 and CD123 expression on AML blasts was studied by flow cytometry in a cohort of 319 patients with detailed inf...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Ehninger, A, Kramer, M, Röllig, C, Thiede, C, Bornhäuser, M, von Bonin, M, Wermke, M, Feldmann, A, Bachmann, M, Ehninger, G, Oelschlägel, U
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2014
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4080210/
https://ncbi.nlm.nih.gov/pubmed/24927407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2014.39
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky